Sexual Health

CytoDyn submits first part of biologics license application to FDA for flagship HIV drug leronlimab

By
1 Mins read
115
0
Share
Reading Time: < 1 minute

A researcher in a lab

CytoDyn Inc (OTCMKTS:CYDY), a Vancouver-based biotech announced Monday that it has filed the non-clinical portion of a Biologics License Application for its flagship leronlimab (PRO 140) as a combination therapy for HIV using the US Food and Drug Administration (FDA)’s rolling review process.  Read More

115
0
Share
Related posts
Sexual Health

Four members of Syrian family 'sexually abuse nine girls aged 11 to 17 at German swimming pool'

By
1 Mins read
Reading Time: < 1 minuteFour members of a Syrian family have been accused of sexually abusing girls aged 11 to 17 at a swimming pool in Germany. …
Sexual Health

My partner is paralysed from the waist down - people ask us how we have sex, here's what we do

By
1 Mins read
Reading Time: < 1 minuteA spinal injury sufferer who can feel ‘nothing from the waist down’ has shared a series of revealing videos that explain how…
Sexual Health

Doctors sound the alarm over rapidly growing cancers linked to risky sexual act

By
1 Mins read
Reading Time: < 1 minuteDoctors are growing increasingly concerned over the rise of cancers linked to a common virus spread by risky sex.  Read More
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.